Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myelodysplastic Syndromes 160Leukemia, Myeloid, Acute 123Leukemia, Myelomonocytic, Chronic 65Leukemia 35Myeloproliferative Disorders 23Primary Myelofibrosis 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Anemia, Refractory, with Excess of Blasts 11Hematologic Neoplasms 10Myelodysplastic-Myeloproliferative Diseases 9Recurrence 8Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Neoplasms 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Polycythemia Vera 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Hematologic Diseases 4Anemia, Refractory 4Thrombocythemia, Essential 3Prostatic Neoplasms 3Neoplasm, Residual 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3

Interventions

bosutinib 1Imatinib Mesylate 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Processes × Azacitidine × Myeloid × Clear all
NCT01201811 2019-12-05

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Celgene

Phase 4 Completed
44 enrolled 26 charts
Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Neoplasms, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡